Khasraw, M., McDonald, K., Yip, S., Verhaak, R., Heimberger, A., Hall, M., … Lwin, Z. (2018). NUTMEG: A RANDOMISED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM): TRIAL IN PROGRESS. In NEURO-ONCOLOGY (Vol. 20, pp. 235–235). New Orleans, LA: OXFORD UNIV PRESS INC.

Khasraw, Mustafa, Kerrie McDonald, Sonia Yip, Roel Verhaak, Amy Heimberger, Merryn Hall, Lauren Fisher, et al. “NUTMEG: A RANDOMISED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM): TRIAL IN PROGRESS.” In NEURO-ONCOLOGY, 20:235–235. OXFORD UNIV PRESS INC, 2018.

Khasraw M, McDonald K, Yip S, Verhaak R, Heimberger A, Hall M, et al. NUTMEG: A RANDOMISED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM): TRIAL IN PROGRESS. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2018. p. 235–235.

Khasraw, Mustafa, et al. “NUTMEG: A RANDOMISED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM): TRIAL IN PROGRESS.” NEURO-ONCOLOGY, vol. 20, OXFORD UNIV PRESS INC, 2018, pp. 235–235.

Khasraw M, McDonald K, Yip S, Verhaak R, Heimberger A, Hall M, Fisher L, Barnes E, Rosenthal M, Gedye C, Hovey E, Ellingson B, Simes J, Tognela A, Koh E-S, Gan H, Back M, Lwin Z. NUTMEG: A RANDOMISED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM): TRIAL IN PROGRESS. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2018. p. 235–235.